Clinical Trial: Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06823063) titled 'Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD' on Jan. 14.

Brief Summary: To evaluate the safety and tolerability of IxCell hUC-MSC-P in the treatment of patients with connective tissue disease-related interstitial lung disease.

To evaluate the efficacy, pharmacokinetics and immunogenicity of IxCell hUC-MSC-P in the treatment of connective tissue disease-associated interstitial lung disease (CTD-ILD).

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: CTD-ILD

Intervention: BIOLOGICAL: MSC

a single injection dose i.v.

Recruitment Status: NOT_YET_REC...